Navigation Links
TNO and Seventh Wave sign letter of intent on joint preclinical pharmaceutical outsourcing services
Date:11/9/2009

rong>By simulating accurately the human conditions in the gastrointestinal tract, the TIM system gives insight into the release, solubility, and availability for absorption of pharmaceuticals. This state-of-the-art, validated system has a much higher predictive value than regular dissolution tests. The computer-regulated model can simulate various physiologic states and helps scientists determine the bioaccessibility of active compounds and predict resultant blood concentration after single or repeated intake of various dosage forms.


TNO - http://www.tno.nl/pharma
TNO is an innovative, independent research organization. Through its expertise and the research it conducts, TNO contributes to the quality of work and life in the world. TNO supports and stimulates innovations in companies and organizations, thus improving the competitiveness of the economy. TNOs multidisciplinary approach and ability to apply research give it a unique position. More than 4300 professionals work at TNO.

Seventh Wave - www.7thwavelabs.com

Seventh Wave is a consulting and contract research organization providing integrated preclinical ADME/PK, pharmacology, toxicology, pathology, and clinical PK. With a continuous commitment to quality, Seventh Wave operates its consulting and laboratory services as an extension of its clients project teams in the design and timely execution of their preclinical development strategies.


Contact
(in US)
Albert Stevens
Tel: +31 6 15631194

(in Europe)
Heather Wagner
Tel: +31 306944615

Info-pharma@tno.nl
www.tno.nl/pharma


'/>"/>
b3c newswire

0

GOOD

Page: 1 2

Related biology news :

1. AACR to host Seventh Annual International Conference on Frontiers in Cancer Prevention Research
2. Titanium Group Signs Letter of Intent to Acquire Multimilion Dollar Medical Software Company and Its Existing Sales Network
3. Titanium Group Signs Letter of Intent to Acquire Multimilion Dollar Medical Software Company and Its Existing Sales Network
4. FEBS Letters Structured Digital Abstracts experiment
5. BIO-key(R) Issues Open Letter to Shareholders
6. Explorations Group Announces Letter of Intent to Acquire Specialty Lighting Company
7. Explorations Group Announces Letter of Intent to Acquire Specialty Lighting Company
8. Selected personal letters of Max Perutz are released in new book
9. NEWSLETTER: Antibody Fragment Production Breakthrough with 2nd Generation EBA
10. Taser Notices Intent to Serve Subpoena for Information on Old NIJ Tests in Taser v. Stinger
11. Wii bit of fun at Rice University has serious intent

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)...single bacterial gene into yeast, researchers from... achieved three improvements in bioethanol product...l, less acetate and elimination of the major by-pr...hed in the scientific journal Applied and Environ...l is made by the yeast Saccharomyces cerevisiae fr...
(Date:11/20/2009)...in German . , In the current online issue o...fanie Eyerich and Dr. Kilian Eyerich together with... Istituto Dermopatico dell,Immacolata in Rome, pre... a milestone on the way to developing new treatmen...soriasis and allergic reactions and potentially al...
(Date:11/20/2009)...ry disease (COPD), a respiratory disease commonly ...ourth leading cause of death worldwide. 600 milli...e yet to find any real treatment or cure, Grace Pa...ity of Western Ontario in London, Canada, is using...to the disease. , Parraga is a scientist in ...
Breaking Biology News(10 mins):Delft breakthrough in bioethanol production from agricultural waste 2Discovery of new type of immune cells regulating inflammation in chronic diseases 2Gaining a better picture of lung disease 2Emerging Washington State Health Care Model Secures 247 5 Million in Venture Capital 50894 1Emerging Washington State Health Care Model Secures 247 5 Million in Venture Capital 50894 2Emerging Washington State Health Care Model Secures 247 5 Million in Venture Capital 50894 3Emerging Washington State Health Care Model Secures 247 5 Million in Venture Capital 50894 4Emerging Washington State Health Care Model Secures 247 5 Million in Venture Capital 50894 5Catalyst Biosciences Announces Agreement With MedImmune to Discover and Develop Engineered Protease Therapeutics 50892 1Catalyst Biosciences Announces Agreement With MedImmune to Discover and Develop Engineered Protease Therapeutics 50892 2CareFusion Files Amended Form 10 Registration Statement With SEC 50890 1CareFusion Files Amended Form 10 Registration Statement With SEC 50890 2CareFusion Files Amended Form 10 Registration Statement With SEC 50890 3
...MES, Iowa -- Iowa State University researcher Robe...ins have controlled motions. , Most biochemists ...ncontrolled movements. , Research conducted by Je...nformatics and Biological Statistics together with...ience and graduate student Lei Yang, over a 10-yea...
...uergen Tautz from the University of Wuerzburg will... the 2008 EMBO Award for Communication in the Life...tion (EMBO) awards the prize annually to a practic...ion with the public. The additional award was made...ication activity on a single organism using all av...
...he Ecological Society of America today criticized ...terpret the Endangered Species Act, which would im...t for federal projects to undergo independent scie...encies to decide for themselves whether their proj..."The concept of independent scientific review has ...
Other Biology News:Iowa State University researcher shows proteins have controlled motions 2EMBO recognizes German zoologist for public communication 2Ecological Society of America criticizes administration's overhaul of the Endangered Species Act 2
(Date:11/19/2009)... World,s Top Gene Synthesis Companies...C) to Coordinate Best Practices in Risk Reduction ...orldwide Gene Synthesis Capacity , ... world’s leading gene synthesis companies to...mon screening protocol to promote biosecurity in t...
(Date:11/18/2009)...at the National Institute of Standards and Technol...nexpensive method for detecting and measuring elus...s, invisible spoilage in food or pesticides distri...od is more sensitive than conventional techniques ... polarlike water molecules, having distinct electr...
(Date:11/18/2009)...RICHMOND, Calif., Nov. 18 /PRNewswire-FirstCall/ -...nced today that data from the University of Pennsy... of Sangamo,s zinc finger nuclease (ZFN) based pro...d prematurely disclosed on the internet. ,, Dat...sity of Pennsylvania School of Medicine from a sin...
(Date:11/18/2009)..., NEW YORK, Nov. 18 Reportlinker...s available in its catalogue. ,, Biotechnolog... http://www.reportlinker.com/p0164375/Biotechnolog...source=prnewswire&utm_medium=pr&utm_campai...gy are complex chemical compounds used in a range ...
Breaking Biology Technology:World's Top Gene Synthesis Companies Establish Tough Biosecurity Screening Protocol 2World's Top Gene Synthesis Companies Establish Tough Biosecurity Screening Protocol 3World's Top Gene Synthesis Companies Establish Tough Biosecurity Screening Protocol 4Prototype NIST method detects and measures elusive hazards 2Sangamo BioSciences Provides Update on Phase 1 Safety Trial of SB-728-T for HIV/AIDS 2Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 2Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 3Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 4Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 5Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 6Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 7Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 8
... July 1 Microfluidic Systems Inc.,(MFSI) announce...ement for,the production of Microfluidic - Bioagen...rd is the fourth in a series of funded phases by t...03. The continued funding,through March 2009, will...ems for extended field trials in key locations aro...
...ly 1 The Delaware Valley,Innovation Network (DVIN...n,Investment Grant. The Wistar Institute will rece...ician Training (BTT) Program, a two-year workforce...al research., The BTT Program provides Community ... and hands-on experience training while preparing ...
...ly 1 Healthation, a healthcare,technology company...n Third,Party Administrator (TPA) to a 10 year con...al-time, rules-based AcceleHealth(R) benefits and ...Portal to deliver interactive,self-service capabil... and,pharmacy lines of business., They will imple...
Other Biology Technology:Microfluidic Systems Receives Continued Funding From the Department of Homeland Security (DHS) Toward the Commercial Production of Autonomous Airborne Pathogen Detection Systems 2Microfluidic Systems Receives Continued Funding From the Department of Homeland Security (DHS) Toward the Commercial Production of Autonomous Airborne Pathogen Detection Systems 3Delaware Valley Innovation Network Awards First Innovation Investment Grant to the Wistar Institute 2Delaware Valley Innovation Network Awards First Innovation Investment Grant to the Wistar Institute 3Healthation Chosen by Large Canadian Third Party Administrator to Support All Employee Benefits and Claims Administration 2
Mouse Anti-Human Acetylcholinesterase, brain (AChE) Monoclonal Antibody, Unconjugated, Clone 12B4 from AntibodyShop A/S
...sed to study co-translational and initial post-tra...ts such as signal peptide cleavage, membrane inser...examined by the translation of the appropriate mRN...branes. In addition, processing and glycosylation ...
Mouse Anti-Polio component type I Monoclonal Antibody, Unconjugated, Clone 9B4 from AntibodyShop A/S
Mouse Anti-Glucagon-like peptide-1 (GLP-1 (1-36) amide) Monoclonal Antibody, Unconjugated, Clone 9F8 from AntibodyShop A/S
Biology Products: